Who Owns NRC Health Company?

Who Owns NRC Health?

Understanding NRC Health's ownership is key to grasping its strategic direction and industry influence. The recent CEO transition, with Trent Green taking over on June 1, 2025, from founder Mike Hays, marks a significant leadership change.

NRC Health, founded in 1981, has evolved into a major player in healthcare experience solutions. Its journey from National Research Corporation to its current standing reflects a commitment to humanizing healthcare.

As a publicly traded entity on NASDAQ (NRC), NRC Health's ownership is distributed among various stakeholders, including institutional investors, company insiders, and individual shareholders. The company's market capitalization stood at $336 million with 22.8 million shares outstanding as of July 23, 2025. Its financial performance, with trailing twelve-month revenue of $141 million as of March 31, 2025, influences investor interest and, consequently, ownership dynamics. Analyzing its NRC Health BCG Matrix can offer insights into its product portfolio's market position and growth potential, indirectly impacting ownership perceptions.

NRC Health, originally known as National Research Corporation, was founded in 1981 by Michael D. Hays. For over four decades, Hays served as the company's CEO, significantly shaping its direction and operations. While specific details about initial equity distribution or early angel investors are not widely publicized, Hays's long tenure as CEO until June 2025 underscores his substantial and continuous influence on the company's trajectory.

Founding Vision

Michael D. Hays established the company with a vision to personalize healthcare. This involved creating tools and insights to help healthcare organizations better understand the individuals they serve.

Early Focus

The company's initial efforts concentrated on performance measurement within the healthcare sector. This strategic focus aligned with the founder's objective of enhancing patient understanding.

Founder's Leadership Tenure

Michael D. Hays served as CEO for over 40 years, a testament to his enduring leadership. His role as CEO concluded in June 2025, marking a significant transition.

Succession Planning

The transition of Michael Hays to Chairman of the Board in June 2025 indicates a structured succession plan. This move aims to ensure operational continuity and facilitate new leadership.

Initial Ownership Structure

Specific details regarding the initial equity split among founders or the involvement of early investors are not readily available. However, the founder's long-standing leadership suggests significant initial ownership.

Company Evolution

From its inception, the company has been dedicated to providing performance measurement tools. This core mission reflects the founder's commitment to improving healthcare through data and insights.

Founders and Early Ownership of NRC Health

Michael D. Hays founded NRC Health, then National Research Corporation, in 1981. He led the company as CEO for over four decades, establishing its core mission of enhancing healthcare through personalized insights. While the specifics of early ownership and investor involvement are not detailed, Hays's continuous leadership until June 2025 highlights his foundational role and likely significant initial stake. The company's early focus on performance measurement tools for the healthcare industry directly stemmed from Hays's vision to help organizations understand each individual they serve. This foundational period set the stage for the company's future growth and its approach to understanding patient experiences. The company's business model and revenue streams are deeply rooted in this early focus, as explored further in this article on the Revenue Streams & Business Model of NRC Health.

• Founded in 1981 by Michael D. Hays.
• Initial name was National Research Corporation.
• Michael D. Hays served as CEO until June 2025.
• Early focus on healthcare performance measurement.
• Founder's vision centered on personalizing healthcare.

NRC Health, publicly traded as National Research Corporation on NASDAQ under the ticker NRC, has a history of ownership changes since its inception in 1981, culminating in its public offering in 1996. The company's market capitalization was approximately $336 million as of July 23, 2025, with 22.8 million shares outstanding.

The ownership structure of NRC Health reveals a significant blend of institutional backing and insider commitment. As of July 28, 2025, institutional investors collectively hold 52.59% of the company's shares, indicating a substantial presence of external investment firms and funds. Complementing this, insiders, which include company executives and directors, maintain a considerable stake of 38.29%. This distribution suggests that individuals closely tied to NRC Health's operations and strategy are also significant shareholders. The company's last known funding activity was a Post IPO round on July 31, 2018, which secured $1 million from investors such as OSF HealthCare, OCA Ventures, and First National Bank. For detailed insights into NRC Health ownership and financial health, shareholders can refer to the company's regular filings with the SEC, including its 2024 Annual Report and 2025 Proxy Statement, which offer comprehensive data on its operations and shareholder base, providing clarity on who owns NRC Health.

Understanding NRC Health's Stakeholder Landscape

NRC Health's ownership is characterized by a strong institutional presence and significant insider holdings. This dual ownership structure often reflects confidence from both external financial entities and the company's internal leadership.

• Institutional investors hold 52.59% of NRC Health shares as of July 28, 2025.
• Insiders, including leadership, own 38.29% of the company's stock.
• The company went public in 1996, making it a publicly traded entity.
• Detailed ownership information is available through SEC filings, such as the 2025 Proxy Statement.
• Understanding the Target Market of NRC Health can provide context for its investor base.

The Board of Directors at NRC Health is tasked with steering the company’s strategic path and ensuring its mission is consistently met. As of June 1, 2025, Michael D. Hays, the company's founder, transitioned to the role of Chairman of the Board, with Trent Green stepping in as the new Chief Executive Officer on the same date.

The board's composition generally includes representatives from significant shareholders, the company's founders, and independent members. While specific details on all board members and their ties to major shareholders are not extensively provided, the company's governance framework is detailed in its corporate documents. These include charters for key committees such as the Audit Committee, Compensation and Talent Committee, and Nominating Committee, which define their oversight and decision-making responsibilities. NRC Health is publicly traded on NASDAQ under the ticker symbol NRC, which typically signifies a one-share-one-vote structure for its common stock, though no information on dual-class shares or special voting rights has been specified.

Understanding NRC Health's Governance

NRC Health's corporate governance structure is designed to ensure accountability and strategic alignment. The board plays a crucial role in overseeing the company's operations and long-term vision.

• Board of Directors guides strategic direction.
• Founder Michael D. Hays now serves as Chairman.
• Trent Green appointed CEO on June 1, 2025.
• Publicly traded on NASDAQ (NRC).
• Audit Committee handles governance-related concerns.

The company's commitment to effective governance is further underscored by the Audit Committee's role in reviewing complaints and concerns related to the company's governance practices. This focus on oversight is critical for maintaining investor confidence and ensuring the company operates with integrity. Understanding the Growth Strategy of NRC Health involves recognizing the foundational role of its leadership and board in executing that strategy.

Over the past 3-5 years, NRC Health has seen significant shifts in its leadership and a renewed focus on growth, impacting its overall company profile and strategic direction. These changes are indicative of a company actively managing its shareholder value and investing in future expansion.

The company's strategic pivot towards growth is evident in its accelerated hiring of sales representatives and the introduction of its 'Human Understanding®' platform, enhanced by an AI-driven Huey tool. This platform is designed to deepen personalized healthcare relationships by analyzing patient trust and behavioral patterns, aiming to redefine industry standards.

Leadership Evolution

The recent CEO transition and expansion of the executive team underscore a commitment to dynamic leadership. These changes are geared towards driving innovation and enhancing customer engagement.

Shareholder Value Initiatives

Active share repurchases and consistent dividend increases demonstrate a strong focus on returning capital to shareholders. This financial strategy aims to boost investor confidence and reflect the company's financial health.

Strategic Growth and Innovation

The company's shift from austerity to growth is supported by strategic hiring and the launch of its advanced 'Human Understanding®' platform. This initiative is central to its Mission, Vision & Core Values of NRC Health.

Financial Performance Indicators

Consistent growth in total recurring contract value and a strong adjusted EBITDA margin of 30% in Q2 2025 highlight the company's robust financial performance. These metrics reflect successful execution of its growth strategy.